Sveriges Riksbank
SEK CREDIT OPERATION ANNOUNCEMENT
Bid date, 2021-01-18 | |
Auction date | 2021-01-18 |
Settlement date | 2021-01-18 |
Maturity Date | 2021-04-19 |
Term | 13 weeks |
Interest rate | The Riksbank´s applicable repo rate |
Bid times | 11.00-11.30 (CET/CEST) on the Bid date |
Confirmation of bids to e-mail | eol@riksbank.se |
Offered volume | Unlimited |
The lowest accepted bid volume | 50 million SEK |
Maximum number of bids | 1 |
Allocation Time | 11.45 (CET/CEST) on the Bid date |
Stockholm, 2021-01-18
Bid date, 2021-01-18 | |
Auction date | 2021-01-18 |
Settlement date | 2021-01-18 |
Maturity Date | 2021-07-19 |
Term | 26 weeks |
Interest rate | The Riksbank´s applicable repo rate |
Bid times | 11.00-11.30 (CET/CEST) on the Bid date |
Confirmation of bids to e-mail | eol@riksbank.se |
Offered volume | Unlimited |
The lowest accepted bid volume | 50 million SEK |
Maximum number of bids | 1 |
Allocation Time | 11.45 (CET/CEST) on the Bid date |
Stockholm, 2021-01-18
This is a translation of the Swedish version published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved at www.riksbank.se.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Norsk Hydro5.3.2021 07:32:40 CET | Press release
Norsk Hydro: Invitation to Investor presentation - Hydro agrees to sell Rolling business area to KPS Capital Partners
Aktieselskabet Schouw & Co.5.3.2021 07:32:10 CET | Press release
Annual Report 2020: The conglomerate shows its strength
Aktieselskabet Schouw & Co.5.3.2021 07:32:00 CET | Pressemeddelelse
Årsrapport 2020: Konglomeratet viser sin styrke
Norsk Hydro5.3.2021 07:31:49 CET | Press release
Norsk Hydro: Hydro agrees to sell Rolling business area to KPS Capital Partners for EUR 1,380 million
Heijmans NV5.3.2021 07:31:39 CET | Press release
Heijmans and AM join forces in Feyenoord City Rotterdam
Hyloris Pharmaceuticals5.3.2021 07:02:18 CET | Press release
Hyloris’ Partner AFT Pharmaceuticals Signs Licensing Agreement with Aguettant for Maxigesic® IV in Eight European Markets
F. Hoffmann-La Roche Ltd5.3.2021 07:02:08 CET | Press release
Roche’s Actemra/RoActemra becomes the first biologic therapy approved by the FDA for slowing the rate of decline in pulmonary function in adults with systemic sclerosis-associated interstitial lung disease, a rare, debilitating condition
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom